Clinical Trials Logo

Filter by:
NCT ID: NCT01501305 Not yet recruiting - Diarrhea Clinical Trials

Influence of Carob and Probiotics on Acute Diarrhea in Children

Start date: January 2012
Phase: Phase 1/Phase 2
Study type: Interventional

Comparison of Carob powder with probiotics vs oral hydration solution in diarrhea treatment in children.

NCT ID: NCT01501292 Not yet recruiting - Infertility Clinical Trials

Changes in the Distribution of Mitochondria During Oocyte Maturation

Start date: January 2012
Phase: N/A
Study type: Observational

Cytoplasmatic maturation is an important event in the general maturation of of the oocyte. Mitochondria is one of the major organelles involved in the process of cytoplasmatic maturation. The aim of this study is to investigate the presence and distribution of the mitochondria in the cytoplasma of immature oocytes that are retrieved in the routine in-vitro maturation cycle with intracytoplasmatic sperm injection (ICSI). These oocytes will not undergo ICSI because of their immaturity. Usually, they are discarded. In addition to these immature oocytes the investigators shall also investigate the mitochondria in mature oocytes that underwent ICSI but did not become fertilized and are discarded.

NCT ID: NCT01501045 Completed - Migraine Clinical Trials

Effect of Transmagnetic Stimulation on Conditioned Pain Modulation (CPM)

Start date: January 2011
Phase: N/A
Study type: Interventional

While some indications of the neural circuits involved in the Conditioned Pain Modulation (CPM) process are now available, there is still need to clarify what parts of the brain are essential for this process, whether the spino-brainstem loop is largely sufficient to explain CPM or whether other cerebral and spinal regions such as frontal, somatosensory and other cortical regions contribute substantially. Whereas mere observation of correlation between these circuits while activated by brain imaging is still of considerable interest, direct experimental manipulations by repetitive transcranial magnetic stimulation (rTMS) could even establish insights into causal relationships.

NCT ID: NCT01501032 Withdrawn - Diabetes Type 1 Clinical Trials

Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes

MD-Logic- Cont
Start date: October 2013
Phase: Phase 1
Study type: Interventional

The purpose of this feasibility study is to evaluate the MDLAP (MD-Logic Artificial Pancreas system)automated insulin management system using continuous glucose monitoring (CGM) and subcutaneous insulin pump infusion in individuals with type 1 diabetes. The study will include 3 inpatient admissions (12-24 hr), which will include overnight sleep, over-bolus meal, under-bolus meal and exercise.

NCT ID: NCT01500928 Recruiting - Type 1 Diabetes Clinical Trials

Performance Study of the SOLO 2.0 Insulin Pump

Start date: July 2011
Phase: N/A
Study type: Interventional

The Purpose of the study is to to evaluate the performance of the SOLO (version 2.0) micropump insulin delivery system, in Type 1 diabetic patients who use insulin pumps for their treatment.

NCT ID: NCT01500668 Recruiting - Clinical trials for Catocholamine Induced Finger Necrosis

Botulinum Toxin A for Treatment of Catocholamine Induced Finger Necrosis

Start date: January 2012
Phase: Phase 4
Study type: Interventional

Patients in the intensive care unit (ICU) often require blood pressure support of vasoactive drugs such as amines. Finger necrosis (so called "blue toe syndrome") is a well documented phenomena with incidence reaching as high as 60% in patients receiving vasopressin. Botulinum toxin is a known muscle relaxant used for a variety of medical application. Recently, several reports have demonstrated its effect in vasospastic disorders. It has also been in mice that when administered locally it has a local vasodilatory effect. The goal of this experiment is to compare the effect of Botulinum Toxin administered locally on amine induced finger necrosis.

NCT ID: NCT01500551 Active, not recruiting - Clinical trials for Juvenile Idiopathic Arthritis

Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis

Start date: March 18, 2013
Phase: Phase 2/Phase 3
Study type: Interventional

Evaluate long-term safety and tolerability of tofacitinib in patients with JIA, who have previously participated in tofacitinib JIA studies.

NCT ID: NCT01500239 Completed - Clinical trials for Complicated Intra-Abdominal Infection

A Study Comparing Ceftazidime-Avibactam+Metronidazole Versus Meropenem in Adults With Complicated Intra-abdominal Infections

Start date: April 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effects of Ceftazidime Avibactam plus Metronidazole compared to Meropenem for treating hospitalized patients with complicated intra-abdominal infections.

NCT ID: NCT01500005 Completed - Diabetes Clinical Trials

The Effect of Vitamin D Supplementation on Arterial Stiffness in Diabetic Patients

Start date: August 2010
Phase: N/A
Study type: Interventional

The incidence of type 2 Diabetes Mellitus is increasing at an alarming rate worldwide. Cardiovascular disease is the leading cause of death in patients with type 2 diabetes. Recently, increasing amount of evidence suggests that vitamin D may influence various nonskeletal medical conditions, including cardiovascular disease, hypertension, diabetes, cancer, autoimmune disorders and more. The purpose of this trial is to investigate the effect of vitamin D supplementation on 24 hours blood pressure monitoring, arterial stiffness, oxidative stress and inflammation in vitamin D deficient diabetic patients.

NCT ID: NCT01499745 Not yet recruiting - Clinical trials for Idiopathic Pulmonary Fibrosis

Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients

Start date: January 2012
Phase: N/A
Study type: Interventional

- Idiopathic pulmonary fibrosis (IPF) is a chronic progressive, fibrosing parenchymal lung disease with unknown etiology. The prevalence of IPF is estimated between 2-29 cases per 100,000 in general population with median survival rates of 2-5 years from time of diagnosed. - Dyspnea and chronic dry cough are the prominent symptoms in those patients which cause to impaired functional capacity and quality of life (QOL). - Drug therapy usually is ineffective approach, what makes a call for an effective treatment. - Pulmonary Rehabilitation (PR) had been founded as safe and effective treatment in increasing functional capacity, decrease symptoms and improve QOL mainly among Chronic Obstructive Pulmonary Disease (COPD). However, recently growing evidence also supports the efficiency of PR in IPF patients. - The Aim of the suggested study is to examine the effect of exercise training (ET) at ambulatory pulmonary rehabilitation among IPF patients. - The investigators hypothesize that ET at PR program will increase functional capacity, will decrease level of dyspnea and improve QOL in IPF patients. - Patients and Methods: - 40 IPF patients males and females (aged 30-90 years old) will be recruiting to this study. After clinical assessment they will be randomly allocated to PR group n=20 or to Control group n=20. - All patients will undergo a clinical assessment including medical history, risk factors for IPF and physical examination. On the first meeting at baseline and within one week post intervention (PR) the following measurements will be made: dyspnea score, QOL and physical activity level questionnaires. In addition, anthropometric measurements, echocardiography, blood samples, pulmonary function tests, cardiopulmonary exercise test, battery of functional test and 6 minute walk test (6MWT). - The PR group will participate in 12 weeks of supervised group's ET program. The training program will be consisted two 6 week blocks of 60 min exercise bout twice a week. In the first block the patients will perform aerobic interval training with treadmill walking, cycling, and step climbing. In the second block, subjects will perform longer periods of continuous aerobic exercise, with resistance training by step climbing, unsupported arm/leg exercises with and without dumbbells (0.5-1 kg), and supporting body weight over a chair. Pulmonary function test and 6MWT will be also performed after completing first 6 week block. The control group will be assessed at baseline and after 12 weeks without participating in PR program.